Technical analysis of Edwards Lifesciences Corporation (EW): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions.
Price Performance
| 1 month | +8.06% |
| 3 months | +2.69% |
| Year-to-date | +7.93% |
| 1 year | +11.59% |
| 3 years | +37.19% |
| 5 years | -21.53% |
| 10 years | +207.97% |
52-Week Range
| 52-week High | $96.29 |
| 52-week Low | $74.66 |
| Avg Volume (90d) | 3.9M |
Technical Indicators
| SMA 50 | $88.14 |
| SMA 200 | $85.43 |
| Beta | 0.94 |
| 30-day Volatility (annualised) | 23.3% |
| Price vs SMA 50 | +4.4% |
| Price vs SMA 200 | +7.7% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $85.25 | |
| 2026-01 | $81.36 | -4.6% |
| 2026-02 | $86.47 | +6.3% |
| 2026-03 | $80.08 | -7.4% |
| 2026-04 | $83.50 | +4.3% |
| 2026-05 | $86.47 | +3.6% |
| 2026-06 | $90.46 | +4.6% |
| 2026-07 | $86.07 | -4.9% |
| 2026-08 | $90.75 | +5.4% |
| 2026-09 | $86.32 | -4.9% |
| 2026-10 | $92.01 | +6.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-04 | $0.74 | $1.68B |
| 2026-07-23 | $0.74 | $1.70B |
| 2026-04-23 | $0.73 | $1.60B |
| 2026-02-10 | $0.62 | $1.55B |
| 2025-10-30 | $0.60 | $1.50B |
| 2025-07-24 | $0.62 | $1.49B |
| 2025-04-23 | $0.60 | $1.40B |
Price
| Price | $92.01 (closing price, October 30, 2026) |
| Market Cap | $53.0B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 52.88 |
| Price / Book | 4.99 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.07 |
| Current Ratio | 4.52 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 11.63 |